Global Transdermal Drug Patches Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Transdermal Drug Patches market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Transdermal Drug Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Transdermal Drug Patches market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Transdermal Drug Patches market has been segmented into Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, Others, etc.
By Application, Transdermal Drug Patches has been segmented into Used for Hypertension, Used for Contraception, Used for Analgesia, Used for Smoking Cessation, Used for Angina, Used for Hormone Replacement, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Transdermal Drug Patches market presented in the report. This section sheds light on the sales growth of different regional and country-level Transdermal Drug Patches markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Transdermal Drug Patches market.
The report offers in-depth assessment of the growth and other aspects of the Transdermal Drug Patches market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Transdermal Drug Patches markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Transdermal Drug Patches Market Share Analysis
Transdermal Drug Patches competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Transdermal Drug Patches sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Transdermal Drug Patches sales, revenue and market share for each player covered in this report.
The major players covered in Transdermal Drug Patches are: Noven, Hercon Pharmaceuticals, Johnson & Johnson, Mylan, Immune Pharmaceuticals, Novartis, DURECT Corporation, Teikoku Pharma USA, Agile Therapeutics, Pocono, Xel Pharmaceuticals, etc. Among other players domestic and global, Transdermal Drug Patches market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales, revenue and global market share of Transdermal Drug Patches in 2018 and 2019.
Chapter 3, the Transdermal Drug Patches competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Transdermal Drug Patches market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Transdermal Drug Patches Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transdermal Drug Patches Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Fentanyl Transdermal Patch
1.2.3 Nicotine Transdermal Patch
1.2.4 Buprenorphine Transdermal Patch
1.2.5 Clonidine Transdermal Patch
1.2.6 Oxybutynin Transdermal Patch
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Transdermal Drug Patches Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Used for Hypertension
1.3.3 Used for Contraception
1.3.4 Used for Analgesia
1.3.5 Used for Smoking Cessation
1.3.6 Used for Angina
1.3.7 Used for Hormone Replacement
1.4 Overview of Global Transdermal Drug Patches Market
1.4.1 Global Transdermal Drug Patches Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Noven
2.1.1 Noven Details
2.1.2 Noven Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Noven SWOT Analysis
2.1.4 Noven Product and Services
2.1.5 Noven Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hercon Pharmaceuticals
2.2.1 Hercon Pharmaceuticals Details
2.2.2 Hercon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hercon Pharmaceuticals SWOT Analysis
2.2.4 Hercon Pharmaceuticals Product and Services
2.2.5 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mylan SWOT Analysis
2.4.4 Mylan Product and Services
2.4.5 Mylan Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Immune Pharmaceuticals
2.5.1 Immune Pharmaceuticals Details
2.5.2 Immune Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Immune Pharmaceuticals SWOT Analysis
2.5.4 Immune Pharmaceuticals Product and Services
2.5.5 Immune Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 DURECT Corporation
2.7.1 DURECT Corporation Details
2.7.2 DURECT Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 DURECT Corporation SWOT Analysis
2.7.4 DURECT Corporation Product and Services
2.7.5 DURECT Corporation Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teikoku Pharma USA
2.8.1 Teikoku Pharma USA Details
2.8.2 Teikoku Pharma USA Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teikoku Pharma USA SWOT Analysis
2.8.4 Teikoku Pharma USA Product and Services
2.8.5 Teikoku Pharma USA Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Agile Therapeutics
2.9.1 Agile Therapeutics Details
2.9.2 Agile Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Agile Therapeutics SWOT Analysis
2.9.4 Agile Therapeutics Product and Services
2.9.5 Agile Therapeutics Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pocono
2.10.1 Pocono Details
2.10.2 Pocono Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pocono SWOT Analysis
2.10.4 Pocono Product and Services
2.10.5 Pocono Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Xel Pharmaceuticals
2.11.1 Xel Pharmaceuticals Details
2.11.2 Xel Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Xel Pharmaceuticals SWOT Analysis
2.11.4 Xel Pharmaceuticals Product and Services
2.11.5 Xel Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Transdermal Drug Patches Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Transdermal Drug Patches Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Transdermal Drug Patches Manufacturer Market Share in 2019
3.3.2 Top 6 Transdermal Drug Patches Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Transdermal Drug Patches Sales, Revenue and Market Share by Regions
4.1.1 Global Transdermal Drug Patches Sales and Market Share by Regions (2015-2020)
4.1.2 Global Transdermal Drug Patches Revenue and Market Share by Regions (2015-2020)
4.2 North America Transdermal Drug Patches Sales and Growth Rate (2015-2020)
4.3 Europe Transdermal Drug Patches Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Transdermal Drug Patches Sales and Growth Rate (2015-2020)
4.5 South America Transdermal Drug Patches Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Transdermal Drug Patches Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Transdermal Drug Patches Sales, Revenue and Market Share by Country
5.1.1 North America Transdermal Drug Patches Sales and Market Share by Country (2015-2020)
5.1.2 North America Transdermal Drug Patches Revenue and Market Share by Country (2015-2020)
5.2 United States Transdermal Drug Patches Sales and Growth Rate (2015-2020)
5.3 Canada Transdermal Drug Patches Sales and Growth Rate (2015-2020)
5.4 Mexico Transdermal Drug Patches Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Transdermal Drug Patches Sales, Revenue and Market Share by Country
6.1.1 Europe Transdermal Drug Patches Sales and Market Share by Country (2015-2020)
6.1.2 Europe Transdermal Drug Patches Revenue and Market Share by Country (2015-2020)
6.2 Germany Transdermal Drug Patches Sales and Growth Rate (2015-2020)
6.3 UK Transdermal Drug Patches Sales and Growth Rate (2015-2020)
6.4 France Transdermal Drug Patches Sales and Growth Rate (2015-2020)
6.5 Russia Transdermal Drug Patches Sales and Growth Rate (2015-2020)
6.6 Italy Transdermal Drug Patches Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Transdermal Drug Patches Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Transdermal Drug Patches Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Transdermal Drug Patches Revenue and Market Share by Regions (2015-2020)
7.2 China Transdermal Drug Patches Sales and Growth Rate (2015-2020)
7.3 Japan Transdermal Drug Patches Sales and Growth Rate (2015-2020)
7.4 Korea Transdermal Drug Patches Sales and Growth Rate (2015-2020)
7.5 India Transdermal Drug Patches Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Transdermal Drug Patches Sales and Growth Rate (2015-2020)
7.7 Australia Transdermal Drug Patches Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Transdermal Drug Patches Sales, Revenue and Market Share by Country
8.1.1 South America Transdermal Drug Patches Sales and Market Share by Country (2015-2020)
8.1.2 South America Transdermal Drug Patches Revenue and Market Share by Country (2015-2020)
8.2 Brazil Transdermal Drug Patches Sales and Growth Rate (2015-2020)
8.3 Argentina Transdermal Drug Patches Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Transdermal Drug Patches Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Transdermal Drug Patches Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Transdermal Drug Patches Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Transdermal Drug Patches Sales and Growth Rate (2015-2020)
9.3 Turkey Transdermal Drug Patches Sales and Growth Rate (2015-2020)
9.4 Egypt Transdermal Drug Patches Sales and Growth Rate (2015-2020)
9.5 South Africa Transdermal Drug Patches Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Transdermal Drug Patches Sales and Market Share by Type (2015-2020)
10.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2015-2020)
10.3 Global Transdermal Drug Patches Price by Type (2015-2020)
11 Global Transdermal Drug Patches Market Segment by Application
11.1 Global Transdermal Drug Patches Sales Market Share by Application (2015-2020)
11.2 Global Transdermal Drug Patches Revenue Market Share by Application (2015-2020)
11.3 Global Transdermal Drug Patches Price by Application (2015-2020)
12 Market Forecast
12.1 Global Transdermal Drug Patches Sales, Revenue and Growth Rate (2021-2025)
12.2 Transdermal Drug Patches Market Forecast by Regions (2021-2025)
12.2.1 North America Transdermal Drug Patches Market Forecast (2021-2025)
12.2.2 Europe Transdermal Drug Patches Market Forecast (2021-2025)
12.2.3 Asia-Pacific Transdermal Drug Patches Market Forecast (2021-2025)
12.2.4 South America Transdermal Drug Patches Market Forecast (2021-2025)
12.2.5 Middle East & Africa Transdermal Drug Patches Market Forecast (2021-2025)
12.3 Transdermal Drug Patches Market Forecast by Type (2021-2025)
12.3.1 Global Transdermal Drug Patches Sales Forecast by Type (2021-2025)
12.3.2 Global Transdermal Drug Patches Market Share Forecast by Type (2021-2025)
12.4 Transdermal Drug Patches Market Forecast by Application (2021-2025)
12.4.1 Global Transdermal Drug Patches Sales Forecast by Application (2021-2025)
12.4.2 Global Transdermal Drug Patches Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Transdermal Drug Patches Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Transdermal Drug Patches by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Transdermal Drug Patches Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Noven Basic Information, Manufacturing Base and Competitors
Table 8. Noven Transdermal Drug Patches Major Business
Table 9. Noven Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 10. Noven SWOT Analysis
Table 11. Noven Transdermal Drug Patches Product and Services
Table 12. Noven Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Hercon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Hercon Pharmaceuticals Transdermal Drug Patches Major Business
Table 15. Hercon Pharmaceuticals Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 16. Hercon Pharmaceuticals SWOT Analysis
Table 17. Hercon Pharmaceuticals Transdermal Drug Patches Product and Services
Table 18. Hercon Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Transdermal Drug Patches Major Business
Table 21. Johnson & Johnson Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 22. Johnson & Johnson SWOT Analysis
Table 23. Johnson & Johnson Transdermal Drug Patches Product and Services
Table 24. Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Mylan Basic Information, Manufacturing Base and Competitors
Table 26. Mylan Transdermal Drug Patches Major Business
Table 27. Mylan Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 28. Mylan SWOT Analysis
Table 29. Mylan Transdermal Drug Patches Product and Services
Table 30. Mylan Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Immune Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Immune Pharmaceuticals Transdermal Drug Patches Major Business
Table 33. Immune Pharmaceuticals Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 34. Immune Pharmaceuticals SWOT Analysis
Table 35. Immune Pharmaceuticals Transdermal Drug Patches Product and Services
Table 36. Immune Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Transdermal Drug Patches Major Business
Table 39. Novartis Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Transdermal Drug Patches Product and Services
Table 42. Novartis Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. DURECT Corporation Basic Information, Manufacturing Base and Competitors
Table 44. DURECT Corporation Transdermal Drug Patches Major Business
Table 45. DURECT Corporation Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 46. DURECT Corporation SWOT Analysis
Table 47. DURECT Corporation Transdermal Drug Patches Product and Services
Table 48. DURECT Corporation Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Teikoku Pharma USA Basic Information, Manufacturing Base and Competitors
Table 50. Teikoku Pharma USA Transdermal Drug Patches Major Business
Table 51. Teikoku Pharma USA Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 52. Teikoku Pharma USA SWOT Analysis
Table 53. Teikoku Pharma USA Transdermal Drug Patches Product and Services
Table 54. Teikoku Pharma USA Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Agile Therapeutics Basic Information, Manufacturing Base and Competitors
Table 56. Agile Therapeutics Transdermal Drug Patches Major Business
Table 57. Agile Therapeutics Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 58. Agile Therapeutics SWOT Analysis
Table 59. Agile Therapeutics Transdermal Drug Patches Product and Services
Table 60. Agile Therapeutics Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Pocono Basic Information, Manufacturing Base and Competitors
Table 62. Pocono Transdermal Drug Patches Major Business
Table 63. Pocono Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 64. Pocono SWOT Analysis
Table 65. Pocono Transdermal Drug Patches Product and Services
Table 66. Pocono Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Xel Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Xel Pharmaceuticals Transdermal Drug Patches Major Business
Table 69. Xel Pharmaceuticals Transdermal Drug Patches Total Revenue (USD Million) (2017-2018)
Table 70. Xel Pharmaceuticals SWOT Analysis
Table 71. Xel Pharmaceuticals Transdermal Drug Patches Product and Services
Table 72. Xel Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Transdermal Drug Patches Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Transdermal Drug Patches Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Transdermal Drug Patches Sales by Regions (2015-2020) (K Units)
Table 76. Global Transdermal Drug Patches Sales Market Share by Regions (2015-2020)
Table 77. Global Transdermal Drug Patches Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Transdermal Drug Patches Sales by Countries (2015-2020) (K Units)
Table 79. North America Transdermal Drug Patches Sales Market Share by Countries (2015-2020)
Table 80. North America Transdermal Drug Patches Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Transdermal Drug Patches Revenue Market Share by Countries (2015-2020)
Table 82. Europe Transdermal Drug Patches Sales by Countries (2015-2020) (K Units)
Table 83. Europe Transdermal Drug Patches Sales Market Share by Countries (2015-2020)
Table 84. Europe Transdermal Drug Patches Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Transdermal Drug Patches Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Transdermal Drug Patches Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Transdermal Drug Patches Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Transdermal Drug Patches Sales by Countries (2015-2020) (K Units)
Table 89. South America Transdermal Drug Patches Sales Market Share by Countries (2015-2020)
Table 90. South America Transdermal Drug Patches Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Transdermal Drug Patches Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Transdermal Drug Patches Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Transdermal Drug Patches Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Transdermal Drug Patches Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Countries (2015-2020)
Table 96. Global Transdermal Drug Patches Sales by Type (2015-2020) (K Units)
Table 97. Global Transdermal Drug Patches Sales Share by Type (2015-2020)
Table 98. Global Transdermal Drug Patches Revenue by Type (2015-2020) (USD Million)
Table 99. Global Transdermal Drug Patches Revenue Share by Type (2015-2020)
Table 100. Global Transdermal Drug Patches Sales by Application (2015-2020) (K Units)
Table 101. Global Transdermal Drug Patches Sales Share by Application (2015-2020)
Table 102. Global Transdermal Drug Patches Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Transdermal Drug Patches Market Share Forecast by Regions (2021-2025)
Table 104. Global Transdermal Drug Patches Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Transdermal Drug Patches Market Share Forecast by Type (2021-2025)
Table 106. Global Transdermal Drug Patches Sales Forecast by Application (2021-2025)
Table 107. Global Transdermal Drug Patches Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Transdermal Drug Patches Picture
Figure 2. Global Sales Market Share of Transdermal Drug Patches by Type in 2019
Figure 3. Fentanyl Transdermal Patch Picture
Figure 4. Nicotine Transdermal Patch Picture
Figure 5. Buprenorphine Transdermal Patch Picture
Figure 6. Clonidine Transdermal Patch Picture
Figure 7. Oxybutynin Transdermal Patch Picture
Figure 8. Others Picture
Figure 9. Transdermal Drug Patches Sales Market Share by Application in 2018
Figure 10. Used for Hypertension Picture
Figure 11. Used for Contraception Picture
Figure 12. Used for Analgesia Picture
Figure 13. Used for Smoking Cessation Picture
Figure 14. Used for Angina Picture
Figure 15. Used for Hormone Replacement Picture
Figure 16. Global Transdermal Drug Patches Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Transdermal Drug Patches Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Transdermal Drug Patches Sales Market Share by Manufacturer in 2019
Figure 37. Global Transdermal Drug Patches Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Transdermal Drug Patches Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Transdermal Drug Patches Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 42. Global Transdermal Drug Patches Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Transdermal Drug Patches Revenue Market Share by Regions (2015-2020)
Figure 44. Global Transdermal Drug Patches Revenue Market Share by Regions in 2018
Figure 45. North America Transdermal Drug Patches Sales and Growth Rate (2015-2020)
Figure 46. Europe Transdermal Drug Patches Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Transdermal Drug Patches Sales and Growth Rate (2015-2020)
Figure 48. South America Transdermal Drug Patches Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Transdermal Drug Patches Sales and Growth Rate (2015-2020)
Figure 50. North America Transdermal Drug Patches Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Transdermal Drug Patches Sales Market Share by Countries (2015-2020)
Figure 52. North America Transdermal Drug Patches Sales Market Share by Countries in 2018
Figure 53. North America Transdermal Drug Patches Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Transdermal Drug Patches Revenue Market Share by Countries in 2018
Figure 55. United States Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Canada Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Mexico Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Europe Transdermal Drug Patches Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Transdermal Drug Patches Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Transdermal Drug Patches Revenue Market Share by Countries in 2019
Figure 61. Germany Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 62. UK Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 63. France Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Russia Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Italy Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Asia-Pacific Transdermal Drug Patches Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Transdermal Drug Patches Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Transdermal Drug Patches Revenue Market Share by Regions 2019
Figure 69. China Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Japan Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Korea Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 72. India Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Southeast Asia Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 74. South America Transdermal Drug Patches Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Transdermal Drug Patches Sales Market Share by Countries in 2019
Figure 76. South America Transdermal Drug Patches Revenue Market Share by Countries in 2019
Figure 77. Brazil Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Argentina Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Middle East and Africa Transdermal Drug Patches Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Transdermal Drug Patches Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Transdermal Drug Patches Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Transdermal Drug Patches Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Egypt Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Turkey Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 86. South Africa Transdermal Drug Patches Sales and Growth Rate (2015-2020) (K Units)
Figure 87. Global Transdermal Drug Patches Sales and Growth Rate (2021-2025) (K Units)
Figure 88. Global Transdermal Drug Patches Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Transdermal Drug Patches Market Forecast (2021-2025) (K Units)
Figure 90. Europe Sales Transdermal Drug Patches Market Forecast (2021-2025) (K Units)
Figure 91. Asia-Pacific Sales Transdermal Drug Patches Market Forecast (2021-2025) (K Units)
Figure 92. South America Sales Transdermal Drug Patches Market Forecast (2021-2025) (K Units)
Figure 93. Middle East & Africa Sales Transdermal Drug Patches Market Forecast (2021-2025) (K Units)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets